Pay in 4 interest-free payments of $6.56 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Mi Y, Zhao J, Feng SS
Watson K, Nasca C, Aasly L, McEwen B, Rasgon N (2018) Insulin resistance, an unmasked culprit in depressive disorders: promises for interventions
As an analog of endogenous growth hormone-releasing hormone (GHRH), tesamorelin boasts a metabolism-stimulating activity that has led to its being approved as a treatment for lipodystrophy, or abnormal adipose fat accumulation associated with antiretroviral therapy for HIV.3 But this same activity can help non-HIV individuals shed abdominal fat of their own, while the peptides GHRH properties make it a suitable therapy for people looking to increase their lean mass
This made it possible to discover peptides in low abundance, including hormone precursors and processing intermediates which could not be characterised by other means at the time
J Exp Life Sci
